US market drag keeps Dr Reddy’s, Cipla under pressure despite strong product pipeline

Indian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy’s and Cipla saw significant drops in their net profits and operating margins. However, their domestic businesses continued to perform well, offering a positive outlook. Obesity therapies and specialty product launches are expected to drive future growth for these companies….

August Rush: Over 2 dozen companies plan Street debut next month

India’s primary market momentum continues with over two dozen issuers planning IPOs. These companies aim to collectively raise approximately ₹35,000 crore in the upcoming month. New-age companies like Zepto and PhonePe are expected to lead this significant market activity. Investor appetite is returning as markets stabilize, following a subdued first half. This robust pipeline signals…

Global Market Today: Oil falls, Asian stocks rise as Iran tensions ease

Global markets saw oil prices fall and stocks rise as US and Iran paused retaliatory strikes. The dollar weakened against peers while Treasuries gained as inflation concerns receded. Traders now await Federal Reserve interest rate decisions and tech company earnings reports. Central banks globally will emphasize vigilance over higher energy prices impacting inflation. Singapore tightened…

Traders are getting a new tool to bet on biggest US stocks

CME Group will introduce single-stock futures for over fifty major US companies. These contracts offer leveraged exposure without the complexity of options trading. The exchange aims to attract new traders and manage risk for institutions. This new financial product is designed for both retail and institutional investors. It aims to capitalize on current market trends…